24 March 2022

APLAR TGA

Shingles jab wins TGA approval for wider age group

3 March 2022

COVID-19 TGA

Access concerns for “game-changing” covid therapy

17 February 2022

COVID-19 TGA

New covid treatment options for immunocompromised patients

18 November 2021

Comment Evidence Based Rheuma Humour TGA

Private health insurance must kick its alt-med habit

28 September 2021

Ankylosing Spondylitis Corticosteroids COVID-19 TGA

TGA approves more covid drugs

2 September 2021

TGA

ARA calls for changes to b/tsDMARD prescribing

25 August 2021

Comment TGA

Medicinal cannabis and stigma: the elephant in the room

29 July 2021

TGA

Confidence in TGA jeopardised by quackery

29 July 2021

Biologics COVID-19 TGA

Covid-19 impacts on people with rheumatic disease: survey

15 April 2021

Biologics Gout TGA

What now for JAK inhibitors?

5 March 2021

Gout Spondyloarthritis TGA

Gilead pulls plug on filgotinib for Australian RA patients

8 February 2021

Biologics Gout TGA

Tofacitinib safety for RA in doubt

8 April 2020

Medications TGA

Hunt promises hydroxychloroquine for hospitals

23 October 2019

Complementary TGA

Google does no evil with stem cell ad ban